| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
468 |
328 |
$51K |
| A0425 |
Ground mileage, per statute mile |
34 |
24 |
$11K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
138 |
104 |
$10K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
54 |
41 |
$9K |
| 87400 |
|
18 |
17 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
15 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
78 |
49 |
$5K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18 |
17 |
$4K |
| 80053 |
Comprehensive metabolic panel |
183 |
157 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
232 |
200 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$869.48 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15 |
15 |
$400.67 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$338.39 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
34 |
33 |
$259.88 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
15 |
$142.80 |
| 83735 |
|
13 |
13 |
$34.68 |